CuraVac Europe S.A.

CuraVac is a clinical-stage biotech company developing the medical and commercial potential of a revolutionary technique for the production of specific Therapeutic Vaccines for the treatment of autoimmune diseases. The company was founded by a Belgian medical doctor, Dr. Stéphane Huberty, who at the time, suffered from myasthenia gravis. The original discoverer of the Vaccine production technique, Professor J. Edwin Blalock soon joined CuraVac as a consultant.